Understanding protein interactions within the complexity of a living cell is challenging, but techniques coupling affinity purification and mass spectrometry have enabled important progress to be made in the past 15 years. As identification of protein-protein interactions is becoming easier, the quantification of the interaction dynamics is the next frontier. Several quantitative mass spectrometric approaches have been developed to address this issue that vary in their strengths and weaknesses. While isotopic labeling approaches continue to contribute to the identification of regulated interactions, techniques that do not require labeling are becoming increasingly used in the field. Here, we describe the major types of label-free quantification used in interaction proteomics, and discuss the relative merits of data dependent and data independent acquisition approaches in label-free quantification.
Introduction
To understand how proteins function inside a cell requires the analysis of their interactions with other molecules, including other proteins. While many protein-protein interactions are largely constitutive, for example those involved in the makeup of molecular machineries such as the ribosome, many interactions are modulated in a condition dependent manner, including those regulated by post-translational modifications [1] . While characterization of complex interaction networks requires only identification of these proteins, obtaining a dynamic view of the interactome necessitates quantitative analysis.
Several approaches have been developed to identify protein-protein interactions. These include enrichment procedures, of which an affinity-tagging protein purification (AP) is the most common, as well as approaches based on the use of reporter expression or visualization. As reviewed elsewhere, these latter methods include yeast two-hybrid approaches and related technologies based on the protein reconstitution brought upon by interaction of fusion partners, as well as fluorescence or bioluminescence transfer approaches between two proteins in close proximity (FRET and BRET) [2] . However, only a few of these techniques are compatible with monitoring dynamically regulated proteinprotein interactions in a semi-quantitative or quantitative manner. Many of the methods available for probing the dynamic nature of protein interactions couple affinity purification with a detection strategy compatible with quantification. For example, one particularly suitable approach to analyze interaction dynamics, LUMIER, has coupled affinity purification (of a bait protein) with detection of a prey protein via luminescence measurements, the prey protein being in this case fused to a luciferase protein [3] .
Protein quantification and expression analysis have been performed for many years. Techniques such as immunoassay (enzyme-linked immunosorbent assay; ELISA) and immunoblotting (commonly known as Western blotting) have been used to provide quantification of biomolecules [4] . However, antibody-based measurements require the development of specific antibodies to the biomolecule of interest, which can be both time-consuming and costly, although we note that several collaborative projects aim at generating affinity reagents to every protein [5] [6] [7] . In particular, accurate quantification based on antibodies requires the generation and validation of high-quality reagents, which can be a long and expensive process. It is also impractical to generate an antibody library to every form of a protein, e.g. splice variants and post-translationally modified forms, especially as the knowledge of modified forms is constantly growing. Furthermore, although significant progress has been accomplished in multiplexing antibody-based assays [8] [9] [10] [11] [12] , the approach still has clear limits as to the number of proteins that can be assessed simultaneously. This, together with a lack of appropriate antibodies to a large number of proteins means that the use of Western blots or ELISAs for protein network level quantification is not practical. Besides issues of availability and multiplexing, there are additional issues related to relying on antibodies for quantification. For example, cross-reactivity with other proteins (for example when the epitope recognized by the antibody is not known) may affect the quantification. In the case of protein-protein interaction studies, the epitope recognized by the antibody may additionally overlap with the binding site for one or more proteins, resulting in an underestimation of the protein abundance and/or the displacement of protein interactions.
As an alternative to ELISA or Western blot methods, there has been a gradual shift towards using mass spectrometry as a method to simultaneously identify and quantify proteins in samples [13, 14] . Mass spectrometry has allowed the development of highly multiplexed quantitation assays, providing a mechanism for their rapid development without many of the issues or the long lead-time of antibody based methods. LC-MS/MS has also increased the understanding of how protein isoforms and post-translational modifications (PTMs) control and regulate multiple cellular processes.
In the case of interaction proteomics, affinity purification has been coupled to a variety of quantitative mass spectrometry approaches. For the purpose of this discussion, we categorize the mass spectrometry acquisition strategies into "Data-Dependent Acquisition", DDA, or "Data-Independent Acquisition", DIA. By far the most common use of DDA is for identification of compounds through "shotgun" techniques. In these experiments, a parent ion is chosen for fragmentation based on a simple set of heuristic rules, usually parent ion intensity, and the MS/MS spectra derived from the selected parent ions are utilized for identification (Fig. 1) . By contrast, data independent acquisition does not select ions to be fragmented based on information in the precursor ion scan, and true DIA approaches aim at fragmenting the entire set of precursor ions in the visible range of the mass spectrometer. As discussed in detail below, this distinction between the selection of ions for fragmentation has important impacts in the resulting quantification.
Continual innovations in mass spectrometric instruments have resulted in dramatic improvements in the sensitivity of detection, allowing the detection of lower level components within samples. Besides being able to see deeper into samples, sensitivity improvements allow an increase in the scanning speed of instruments, which has opened the potential to use different workflows and methods for quantitation and identification. Here we discuss approaches for quantitation of peptides and proteins, especially as they apply to the analysis of protein-protein interactions detected from the coupling of affinity purification and mass spectrometry (AP-MS). These approaches are also applicable to a variety of other sample types covering different application areas where quantitation is needed, however the sample complexity ultimately dictates which methods can be employed.
MS intensity or count-based data dependent methods
An efficient way to perform quantification of peptides and proteins is to incorporate a differential isotopic (or in some case isobaric) labeling strategy into the experimental pipeline. Usually, labeled and unlabeled samples are mixed prior to analysis so compound ratios can be determined directly by measuring the corresponding peak intensities. Labels are broadly grouped as those which are covalently attached to peptides, e.g. isotope coded affinity tags, ICAT [15] or iTRAQ [16] , incorporated through enzymatic reactions, e.g. incorporation of 18 O via trypsinization [17] , or metabolically incorporated, e.g. stable isotope labeling with amino acids in cell culture, SILAC [18] . In the context of protein-protein interactions, labeling approaches have most often been used for the identification of background nonspecific binding proteins, but are also appropriate to monitor regulated interactions, as recently reviewed [19] . In general, techniques based on isotope labeling provide excellent results, though recently a number of issues have been documented which relate to the quality of the quantitative measurements [20] , that coupled with long assay development times and issues of scaling to appropriate sample sizes limit the utility of such techniques.
The recent resurgence in label-free approaches has placed different requirements on the analytical methods employed. Conceptually, spectral counting is the simplest label-free analysis method [21, 22] . In an identification experiment (shotgun experiment), the number of MS/MS events triggered for a single peptide can be summed: this sum corresponds to spectral counts, which can be tabulated at the peptide and protein level. Ultimately, the comparison of the relative abundance of a protein across samples is achieved by comparing the spectral counts for all peptides associated with this protein in the different samples [23, 24] . In interaction proteomics, spectral counting and related approaches (such as counting the number of unique peptides, with or without normalization, e.g. for protein length, [25] or even using composite scores [26, 27] ), have been used to discriminate true interactions from non specific binding proteins, or to identify major differences in the interactions between different proteins [23, [28] [29] [30] [31] . We refer the readers to an excellent review on data analysis of AP-MS data using counting approaches for an in-depth discussion of the issue [24, 32, 33] .
To provide reliable information, counting methods do require an instrument that has the ability to sample a LC peak at a high frequency, and therefore the faster the instrument, the higher quality the spectral counting data [34] . Spectral counting approaches are also strongly influenced by the acquisition methods, in particular those which are normally optimized to limit the number of MS/MS events for an individual peptide, such as the dynamic exclusion parameters and the exclusion width. Lastly, as the peak is being sampled more than once, the identification dynamic range is limited, and low-level ions may be missed in preference to the higher intensity ions, limiting the application of spectral counting to moderately to highly abundant proteins, or to proteins whose abundance varies significantly between the samples. Counting approaches are therefore not always appropriate for many important dynamically-regulated interactions.
Area measurements from the intensity of the signal detected in the MS1 scan may be used to provide quantitative information: the mass of interest is extracted across a time domain, resulting in an extracted ion chromatogram (XIC), which is used to integrate the LC elution peak of the In the first mode (MS1) all ions are transmitted through the instrument and detected at the detector which can be subsequently used for parent ion are determinations. The derived MS spectrum is analyzed using simple rules (intensity, charge state and whether the ion has been fragmented before). Ions which pass these simple rules are then isolated and fragmented. (B) In MS/MS mode, specific masses are isolated in the first quadrupole and fragmented in the second. All of the fragment ions are recorded in the analyzer and a MS/MS spectrum generated which can be used for compound identification.
compound of interest. This is similar to the method of processing SILAC data where intensity of spectral peaks of the isotopically codes pairs are determined. The primary difference between these MS1-based label-free approaches and an isotopic labeling approach is that retention time in LC space has to be managed more closely, either by the incorporation of retention time markers or through algorithms which will realign data on retention time. Misalignment may also be mitigated by the use of modern LC systems, which have very good reproducibility in elution, but even in these cases the complexity of proteomic samples may give rise to misalignment. For accurate definition of an LC elution peak, the scan rate of the instrument is important, as insufficient measurements can significantly affect the area determinations (Fig. 2) . Although not explicitly shown on Fig. 2 the reduction of the number of data points across a LC peak can clearly reduce the definition of the peak apex and affect the area determination. The quality of the quantification can also be problematic in shotgun sequencing workflows in which the frequency of the MS1 scans is affected by the selection of ions to fragment and the time spent in sequencing each precursor. This being said, newer generation instruments are able to collect a large number of MS/MS events and also maintain a consistent number of points across the LC elution peak, therefore providing reliable MS1-based quantitation.
In general, MS1-based quantification has been performed hand in hand with identification, in which only the identified species are quantified. However, this requirement for simultaneous identification is not absolute: for example, MS1 quantification is widely used in metabolomics without MS/ MS measurements for the identification of the compounds [35] [36] [37] . In this case, MS1 chromatographic peaks are aligned across samples, and areas are profiled. In proteomics, a similar data reduction process can be employed that consists in aligning MS1 data by mass and retention time across different samples followed by statistical processing to identify masses that show biologically significant differences [38, 39] . This data processing scheme has been enhanced by the prediction of peptide retention times [40] , allowing subsequent identification of compounds in the absence of MS/MS. Within the context of interaction proteomics, an intermediate strategy has also been proposed [41] where identification results from pooled reference samples can be used to target MS1 data extraction and subsequent quantification. This hybrid method allows the extraction of data from the sample in a semi-targeted fashion and in many cases does not require the complex alignment of LC-MS traces.
Although MS1 based methods generally provide relatively accurate quantitation and are rapid, there are a number of issues with the technique. Firstly, when "identified" compounds are not used to target data extraction, the alignment of different MS1 LC peaks across multiple samples requires complex algorithms [42, 43] . Furthermore, when all measured MS1 masses are extracted from complex samples, the potential for overlapping spectral peaks between samples is increased, resulting in convolved data both at the spectral and LC level. Secondly, sample complexity, the specificity of the detection device and also the number of times a LC peak is sampled by a MS1 scan govern the limit of detection (LOD) by introducing a level of noise that cannot be separated from the parent ion signal for lower intensity species. High-resolution mass spectrometry has been used to reduce this effect, however there is a limit to what can be separated by resolution alone. Spengler et al. showed that resolution allows for the identification of peptide elemental compositions [44] , but many peptides can have the same chemical composition and therefore an orthogonal technique is needed to separate the compounds. These factors, coupled with technologies to limit the number of ions entering the detection system, e.g. Automatic Gain Control (AGC), can result in compounds not being detected in all samples or the error of low intensity ions being greater than acceptable.
Experimental methods have been used to mitigate these issues. One common method is sample fractionation, i.e. cation exchange separation [45] , or the use of longer LC gradients with long columns [46, 47] . In all cases, the aim is to minimize as many interferences within a LC-MS peak as possible, thus enabling more accurate measurements of the peptide content of a sample. However, if multidimensional fragmentation is used, it is common to identify the same species in multiple fractions, rendering quantification more complicated. This can be corrected by software, but the processing of fractionated label-free samples remains a challenging problem [48] . This being said, MS1 quantification of AP samples is usually possible in a single LC-MS/MS analysis, as sample complexity is less of an issue, and has in fact been applied to discriminate between true interactions and background noise [49, 24, 30] . We and others have also successfully used affinity purification combined with parent ion area extractions to quantify differential protein interactions [50] .
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Fig. 2 -The number of points which are used to determine the peak shape is critical to the quantitation reproducibility. The balance between the cycle time and peak width is critical for determining the chromatographic peak shape. The recommended minimum number of points used to define the LC peak shape is 8, which should provide a good estimate of the peak apex. The cycle time is a balance between accumulation time and number of ions monitored/ fragmented. In the case of Shotgun proteomics, the LC peak is sampled infrequently, whilst this sampling frequency increase in SRM analysis. It is important to not only have a large number of points to define a peak but the points themselves should be equidistant also.
All methods that depend on DDA (both isotopic and label-free) suffer from the same issue -under sampling of the injected sample that results from the stochastic nature of the DDA method. In DDA experiments, it can be difficult to determine if the absence of a peak area is due to the absence of a compound or if whether it is related to the random nature of detection. This phenomenon increases the measurement variability within a system, lowering confidence in the measurements closest to the detection limits. As proteinprotein interaction studies generally involve proteins at all levels of abundance in the mixture (depending on their relative association with the "bait" protein which is being purified), this randomness limits the amount of network coverage that can be achieved. In attempt to minimize the under sampling effect, different quantitative methods have been developed, which target specific compounds and use MS/MS as a means to improve the selectivity and specificity of the detection; these are discussed below.
MS/MS based and data independent methods
There has been a trend to improve the analytical rigor within peptide-based quantitation experiments, and terms such as "limit of detection" and "limit of quantification" are now widely employed. The use of MS/MS quantitation methods such as Selected Reaction Monitoring (SRM) has provided data that has higher specificity and selectivity than direct parent ion measurements. Furthermore, techniques for data processing developed for drug analysis have brought higher degree of analytical rigor to the field of MS-based quantification.
The most commonly used MS/MS-based quantification approach, SRM (Fig. 3A) , is routinely used in the pharmaceutical industry for bioanalytical studies of multiple compounds, including peptides [51] . As shown in Fig. 3A , SRM is generally performed in a triple quadrupole instrument where a parent molecule is isolated, fragmented and a fragment ion isolated in the final quadrupole, providing superior selectivity of this technique over MS1-based methods [14] . Modern instruments are able to repeat these measurements on the order of 1000 times a second, allowing for the analysis of a vast number of transitions (a term given to the combination of Q1 and Q3 isolation masses) (Fig. 3A) .
SRM methods are not normally considered data independent in the strict sense of the term, but more commonly referred to as "targeted" methods as a list of compounds of interest must be predefined at the onset of the experiment. A targeted SRM assay requires information about the fragmentation of the peptide to be measured and, optimally, its LC retention time. Information about the fragmentation of compounds within the sample is used to define the method; this requires a certain level of iteration to generate the highest quality of quantitative data [52] . In all cases, SRM acquires data whether or not the parent ion is detected and a signal derived, from either background noise or real signal. In contrast to DDA-based methods where the detection is semi random, based on the parent ion mass being selected for fragmentation, SRM enables unbiased measurements of compounds at the lower limits of detection since it performs CID Q1 Q3 m/z counts Standard MRM the window in the middle shows an interfered ion. In this case, it is highly likely that the peak will be convolved and result in a higher variance than the other ion.
constant measurements of peptides/proteins, thus ensuring the removal of any stochastic effects. This allows SRM measurements to achieve accuracy and precision levels that are accepted by regulatory authorities and used in bioanalytical laboratories for the analysis of biomolecules. Acceptance of SRM measurements in proteomics was facilitated with the development of hybrid technologies which allowed the acquisition of high quality MS/MS spectra triggered from SRM signals [52] . This novel combination of mass spectrometry scanning methods provided ability to perform measurements with a high degree of confidence and enabled quantitation of a larger number of proteins [53] [54] [55] . These studies all show that SRM provides measurements that are both consistent and precise across a range of samples and an extended period of time. Importantly, in a key step towards the global adoption of SRM as a robust quantification approach, a multisite validation of SRM assays was undertaken by the CPTAC group [56] , introducing guidelines and a framework for SRM-based measurements and highlighting the possibility of robust multiplexed protein assays running on multiple instruments in many facilities. These reports also identify some of the key issues with SRM methods, namely the need for upfront assay validation and iteration. For example, it is possible that method development for a 100-protein assay takes more than 12 months to identify the correct transitions and confirm the validity of the assay ensuring that there are no "hidden" interferences in the SRM signal (Fig. 3B) . Reducing development time is critical if SRM is to be utilized in more protein quantitation studies, especially as modern instrumentation enabling fast SRM measurements can monitor enough peptides to cover networks of up to 200 proteins. Within the context of interaction proteomics experiments, SRM approaches may be most appropriate for cases where the same bait (or small group of baits) and interactors need to be profiled repeatedly across multiple conditions. For example, Bisson et al. developed an SRM assay centered around the key signaling scaffold protein GRB2 which they then used to profile interaction dynamics following growth factor addition [57] . Such SRM approaches would also enable profiling interactions following the addition of therapeutics and/or across cell lines or patient samples.
In most cases, proteomics assays do not require the full validation of a regulated SRM assay, but analytical testing is essential to ensure that the correct compound is being measured. Analytical verification time has become a key factor in the choice between SRM or other measurements, e.g. spectral counting. Validation and verification of SRM methods centers on ensuring identification of the correct transition signals (peak) and that the most appropriate transitions have been used to gain optimal LOD. This can be a challenge for SRM as the measured signal is derived from a range of fragment mass space, typically 0.5 to 0.7 Da (Fig. 3B) having implications on the selectivity of the measurements. Because peptide fragment ions have similar elemental compositions, MS/MS mass space is very crowded and it is likely that a closely eluting species with a similar Q1/parent mass will also have MS/MS ions or are close enough in mass space to also occupy the Q3/fragment ion mass volume being targeted. These convolved signals will be recorded in the data and require algorithms and statistical approaches to deconvolute the resulting LC-MS/MS signal traces. These issues also exist in MS1 data, but in the case of SRM, a number of different ion signals can be derived from the MS/MS spectra and tested to identify a "clean" LC peak whereas in MS1 there is only a single signal that is either clean or convolved. The identification of potentially convolved ions and selecting of non-convolved alternatives extends SRM method development time as this is generally a manual process, although commercial and publicly available software can help identify potential outlier transitions in an automated manner [58] .
Extensions to the SRM method using subsequent fragmentation of product ions in a process called MS3. This can be used to enhance the selectivity for the targeted compound, mitigating many of the effects described above. MS3 has been used to great effect in lowering the limit of detection for the analysis of peptides as described in Fortin et al. [59] . However, the use of this method does come with some limitations, primarily that the time required to perform the MS3 scan reduces the number of peptides that can be monitored and/or the number of points across the LC peak, and that the method development time is extended beyond the time required to develop the basic SRM assay.
As mentioned above, a limitation of SRM approaches to date has been the requirement for the establishment of the methods, that is the selection of the optimal transitions to be monitored. To facilitate the development of assays, a growing number of resources are becoming available that assist the individual researchers in selecting transitions in a faster time, including collections of spectral libraries derived from both experimental shotgun data and also from the analysis of synthetic peptides [60] [61] [62] [63] . These resources are references for SRM assays that enable faster implementation across platforms and sample types [63] . However, the nature of the synthetic libraries is such that the coverage for proteins is somewhat limited, normally to 4 or 5 peptides per protein. This is most often adequate for the quantification of protein abundance, but usually not for the analysis of a particular isoform or post-translationally modified form, limiting the full utility of the libraries currently available.
Recently, SRM has been extended to modern instruments with high-resolution second mass analyzers [64, 65] that in general collect a full MS/MS spectrum for all targeted compounds. This allows post acquisition identification of potential fragment ion interferences that would have been masked with the use of quadrupole mass resolution (Fig. 4) . The use of high-resolution provides a method with significantly higher specificity than classical SRM, and decreases method development time, as only parent masses for the targeted peptides are selected and all fragment ions and interferences are detected in one analysis. The general applicability of this approach has been impeded by the fact that until recently it was not possible to schedule the analysis of peptides in the high-resolution SRM measurements, significantly limiting the number of ions that could be measured in a single analysis. Instrument vendors further report that in this mode, the limit of detection for complex samples is better than those achieved by MS1 methods but not as good as classical SRM measurements. Although the sensitivity of classical SRM will likely remain better than that of high resolution SRM for the foreseeable future, the ease of use the latter is an important factor that will position this technology as a stepping-stone to performing classical SRM. Furthermore, there may be situations where the extra specificity of the techniques provides improved detection limits.
As mentioned above, although classified here as dataindependent methods, SRM and derivatives are targeted methods that require a list of known compounds and transitions. This targeting means that as a hypothesis develops, samples require reanalysis to target different compounds. In many cases, samples which are being analyzed are either expensive to generate or are irreplaceable, and therefore testing new hypotheses may be impossible. Hence, there has been a need for methods that allow the detection of all compound fragment ions for quantification. It is important to differentiate this concept from SRM, as data acquisition does not target specific compounds. It is also noteworthy to mention that until recently, the use of data independent analysis was focused on protein identification and not protein quantification [66] .
Over the past years, there have been many proposed methods for the analysis of samples using true data independent strategies, which in general fragment all compounds that are within the isolation range of the mass spectrometer, are ionizable at the source and also elute from the chromatographic system. The methods described to date try to balance the cycle time for data collection with the sample complexity and gradient length and attempt to gain sufficient LC peak definition by altering the specificity of parent ion selection. Although methods such as MS E [66] and All Ion Fragmentation (AIF) [67] use cycle times of about 2 seconds, they could in theory scan at much faster cycle times. This form of DIA utilizes a wide band pass filter for selection of ions and subsequent fragmentation of all of the ions. In the case of MS E or more recently HD-MS E , a TOF analyzer is used to detect the fragment ions directly or after Ion mobility separation. AIF utilizes a FT-based orbital trap instrument to detect the fragment ions, and as such should offer higher detection resolution. It should be noted that in these instruments, increasing the residence time to improve the resolution decreases the overall cycle time. The greatest concern with such methods is the specificity of the fragment ion isolation after fragmentation of wide swaths of parent ions that may compromise their uniqueness. Methods such as PAcIFIC [68] or MSMS ALL improve the parent ion selectivity by stepping the isolation window with a much narrower mass filter, in comparison to the DIA approaches outlined above. In the case of PAcIFIC, an isolation window of 2.5 amu is used to step across a small mass range e.g. 45 Da, allowing the use of the technique for LC-based separations. However, to cover the entire parent mass range, multiple sample injections are required, extending the analysis time significantly. In the case of MSMS ALL , the ions are filtered in 0.7 amu steps, offering the highest parent ion selectivity but with a concurrent long cycle time, resulting in this technique being applied thus far primarily for infusion-based experiments, such as lipid analysis [69] .
Alternative DIA methods analyze a window of masses and step this window across the complete mass range of interest in cycle times that are compatible with chromatography. These methods balance the cycle time promised by AIF/MS E and the selectivity of PAcIFIC/MSMS ALL to provide methods which allow a high degree of selectivity and fast LC compatible cycle times (Fig. 5 ). Methods have been described for Ion Trap [70] and also TOF [32] instruments, although the use of ion traps for ion detection, while potentially useful for compound identification [71] , may be less applicable to quantification, as this depends upon the analysis of non-convolved fragment ions. The previous discussion about the use of SRM, and the issues of co-eluting species generating ions which interfere with the Q3 detection mass, also apply to the use of low resolution fragment ion scans for DIA methods in which the wider isolation window of the mass selection device allows more ions into the detection system, compounding the potential for fragment ion convolution. Methods such as MS/MS ALL with SWATH™ Acquisition on a TOF instrument [32] and multiplexed DIA on quadrupoleorbitrap instruments [72] appear to overcome the limitations described above and offer stepped isolation windows with sufficient speed to cover the compound mass range of interest.
Questions remain about the ability of these approaches to maintain the specificity of compounds when compared to established methods such as SRM. Past attempts to determine unique ion signatures for peptide SRM data [73] showed that prediction may be inappropriate using low resolution detection scans, and recently Röst et al. highlighted the need for high resolution detection scans [74] and also pointed to the need for a third factor to enable successful quantification of compounds by DIA, namely retention time. In these studies, selectivity of the signal detection was evaluated, indicating that techniques such as SWATH do in fact provide selectivity similar to SRM.
At this point, it is not clear which instrument(s) are ideal for DIA workflows. In the case of trap based detection systems, the need to limit the number of ions analyzed in order to mitigate space charge effects may reduce the quantitative dynamic range, however space charge effects have recently been shown to coalesce ions of similar mass into single spectra peaks depending upon the intensity of the signal [75] , further impacting the quality of the data. TOF detection systems provide lower resolution (~25,000) than that achieved by FT-based instruments but their higher scan speeds allows faster coverage of the mass range of interest, thereby increasing the number of points across the chromatographic peak and improving quantitation. TOF based detection systems also provide a linear dynamic range that is unaffected by space charge and therefore could prove to be the superior instrument for quantitative DIA.
The use of DIA will likely expand the utility of current libraries and may provide impetus for further development of public libraries. Library generation will likely be an area of expansion, as more people adopt DIA-based quantification. In addition, DIA provides a unique feature, namely a complete digital MS/MS record of all compounds that are detectable within the sample. This record allows a hypothesis to change during a biological study, and hence data from libraries can be used to probe samples for proteins which were not originally targeted or identified within a sample.
Reinterpretation of data after acquisition was described by Gillet et al. who used a SWATH data set to test different hypotheses [32] . This ability of DIA methods opens new avenues for data sharing and testing, but also demands greater information about the sample preparation and cell line/type be stored [76] with the data in public repositories, especially in the case of protein-protein interaction studies where the experimental conditions are critical to understanding the nature of the potential protein interactions.
4.
The future for protein-protein interaction mapping?
With the increasing level of multiplexing available from different MS based methods, the extent of protein interaction networks that can be studied is increasing. More importantly the emerging methods used for peptide and protein quantitation generate data that is complete and unbiased -a fundamental requirement for the study of complete networks or interactomes.
It is clear that there will always be a role for the DDA based methods; they are simple to perform and provide a rapid assessment of the amount of material within a sample. Besides simplicity, there will always be a need for the identification of proteins as well as post-translational modifications. The extent to which the biology of any protein is known in a dynamic system is minimal, and the ever-increasing numbers of splice variants, SNPs, etc. will likely mean that experiments where both quantitation and identification are performed using DDA methods or "discovery quantitation" will be the first method of choice for the foreseeable future. However, the direct path from IDA to a targeted DIA, e.g. SRM, appears to be changing. The development of DIA methods that have the analytical performance of SRM will result in data that can be used to test multiple hypotheses, or even used in different experiments, reducing the amount MS analyses required and changing the emphasis to a bioinformatic issue.
What of SRM? It is clear that DIA methods published to date still lack features that can be found in SRM methods. Although selectivity and specificity are of concern in DIA , reports indicate that many of the issues have been addressed in the case of methods like SWATH [74] , yet the sensitivity of the method appears to be an order of magnitude lower than dedicated SRM [32] . It seems likely that a workflow of experiment as shown in Fig. 6 will emerge starting with a DDA based quantitation method such as MS1 XICs followed by high multiplexing assays such as SWATH where the largest number of proteins can be precisely monitored in a single analysis. As hypotheses develop, the number of proteins that require monitoring will reduce and result in an assay that could be performed through high resolution SRM and ultimately as a standard SRM assay on a high sensitivity triple quadrupole based instrument. This workflow provides a pipeline that starts with lower confidence results and ends using robust and proven technology as the final assay and may prove a future experimental pipeline in biomarker discovery.
Although protein-protein interaction studies appear simple to perform, the data requirements for high quality measurements are stringent. As the number of known protein interactions increases, so does the number of proteins that are required for analysis. This increase requires methods that allow the quantitative analysis of proteins in a consistent manner, and DIA methods provide the best sample coverage. DIA also allows for the analysis of different proteins within a data set without sample reinjection and therefore offers the potential to accelerate the testing of multiple hypotheses in experiments and will serve to accelerate the understanding of how proteins interact in protein networks. In the end, while there is no wrong method for protein quantitation, the selected method must balance performance, development time and the analytical rigor required to the question being asked, and to the biological sample studied. The emergence of new modes of quantification potentially applicable to protein interactions should enable the researcher to select the most appropriate method (or methods) for their problem. Initial hypotheses are developed from the identification of proteins within samples, where MS1 based techniques may be used for quantification. Hypothesis verification requires a greater degree of confidence in the quantification, which is gained by using DIA techniques. Methods such as SWATH allow the modification of hypotheses without the experimental reanalysis of the samples, enabling further refinement of the hypothesis. Hypothesis validation could be performed using methods such as SWATH but as the number of proteins to be monitored decreases with hypothesis refinement, analysis methods can also change to routine monitoring as offered by SRM.
